{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:52:10Z","timestamp":1780109530967,"version":"3.54.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clcc.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T19:00:22Z","timestamp":1663441222000},"page":"297-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment: A Meta-Anaysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"21","author":[{"given":"Milena","family":"Gabbani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Tebano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Missiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mandar\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zaninelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Grigolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-3655","authenticated-orcid":false,"given":"Francesco","family":"Fiorica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2022.07.005_bib0001","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","article-title":"Preoperative radiotherapy for resectable rectal cancer: a meta-analysis","volume":"284","author":"Camm\u00e0","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clcc.2022.07.005_bib0002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0003","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2022.07.005_bib0004","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1200\/JCO.2009.26.9787","article-title":"Improving local control in rectal cancer: radiation sensitizers or radiation dose?","volume":"28","author":"Tepper","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ctrv.2010.03.002","article-title":"Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data","volume":"36","author":"Fiorica","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"iv","key":"10.1016\/j.clcc.2022.07.005_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0007","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"R\u00f6del","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0008","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cncr.30600","article-title":"Total neoadjuvant therapy for rectal cancer: An emerging option","volume":"123","author":"Ludmir","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2022.07.005_bib0009","first-page":"1","article-title":"Total neoadjuvant therapy: a shifting paradigm in locally advanced rectal cancer management","volume":"17","author":"Franke","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2022.07.005_bib0010","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2022.07.005_bib0011","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clcc.2022.07.005_bib0012","unstructured":"RoB 2: A revised Cochrane risk-of-bias tool for randomized trials. Available at: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed: Jul 21, 2022."},{"issue":"3_suppl","key":"10.1016\/j.clcc.2022.07.005_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.2021.39.3_suppl.8","article-title":"NRG-GI002: a phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)\u2014Pembrolizumab experimental arm (EA) primary results","volume":"39","author":"Rahma","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0014","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1200\/JCO.2019.37.15_suppl.3505","article-title":"NRG-GI002: a phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)\u2014First experimental arm (EA) initial results","volume":"37","author":"George","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0015","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/sim.6111","article-title":"Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects","volume":"33","author":"Combescure","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.clcc.2022.07.005_bib0016","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0272989X0002000113","article-title":"An assessment of methods to combine published survival curves","volume":"20","author":"Earle","year":"2000","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"10.1016\/j.clcc.2022.07.005_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clcc.2022.07.005_bib0018","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clcc.2022.07.005_bib0019","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/codi.13724","article-title":"Prospective randomized trial of neoadjuvant chemotherapy during the \u2018wait period\u2019 following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial","volume":"19","author":"Moore","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clcc.2022.07.005_bib0020","first-page":"889","article-title":"A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: kcsg co 14-03","volume":"101","author":"Kim","year":"2018"},{"key":"10.1016\/j.clcc.2022.07.005_bib0021","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/annonc\/mdr473","article-title":"Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study","volume":"23","author":"Mar\u00e9chal","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0022","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"Fern\u00e1ndez-Martos","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0023","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/annonc\/mdu377","article-title":"Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study","volume":"25","author":"Borg","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0024","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jamaoncol.2019.2294","article-title":"Effect of aflibercept plus modified FOLFOX6 induction chemotherapy before standard chemoradiotherapy and surgery in patients with high-risk rectal adenocarcinoma: the GEMCAD 1402 randomized clinical trial","volume":"5","author":"Fern\u00e1ndez-Martos","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0026","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0027","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamaoncol.2021.1683","article-title":"Use of total neoadjuvant therapy for locally advanced rectal cancer: initial results from the pembrolizumab arm of a phase 2 randomized clinical trial","volume":"7","author":"Rahma","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0028","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5\u202f\u00d7\u202f5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0030","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1200\/JCO.2021.39.15_suppl.3510","article-title":"A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): The final reports","volume":"39","author":"Jin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0031","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"The Oncologist"},{"issue":"15_suppl","key":"10.1016\/j.clcc.2022.07.005_bib0032","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2020.38.15_suppl.4102","volume":"38","author":"Fernandez-Martos","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0033","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2288-12-111","article-title":"Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature","volume":"12","author":"Gagnier","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0034","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3390\/cancers13102352","article-title":"Beyond Abscopal Effect: A Meta-Analysis of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer","volume":"13","author":"Fiorica","year":"2021","journal-title":"Cancers"},{"issue":"15_suppl","key":"10.1016\/j.clcc.2022.07.005_bib0035","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1200\/JCO.2021.39.15_suppl.3607","article-title":"A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage","volume":"39","author":"Tamberi","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.07.005_bib0036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.archger.2008.05.001","article-title":"Adjuvant radiotherapy on older and oldest elderly rectal cancer patients","volume":"49","author":"Fiorica","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.clcc.2022.07.005_bib0037","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.archger.2011.08.016","article-title":"Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)","volume":"55","author":"Berretta","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.clcc.2022.07.005_bib0038","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2174\/18715206113136660347","article-title":"Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients","volume":"13","author":"Berretta","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.clcc.2022.07.005_bib0039","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.archger.2010.02.006","article-title":"FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study","volume":"52","author":"Berretta","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.clcc.2022.07.005_bib0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","article-title":"The hazards of scoring the quality of clinical trials for meta-analysis","volume":"282","author":"J\u00fcni","year":"1999","journal-title":"JAMA"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:52Z","timestamp":1761520132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002822001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1533002822001037"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2022.07.005","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment: A Meta-Anaysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}